Back to top Open menu arrow
Download PDF Reprints

The Primary
Care Companionfor CNS Disorders
Free access

Primary Care Companion for CNS Disorders

Letter to the Editor November 10, 2009

Open-Label Trial of Acamprosate as a Treatment for Anxiety

; ;

Prim Care Companion J Clin Psychiatry 2009;11(5):267-267

Article Abstract

Letter to the Editor

Open-Label Trial of Acamprosate as a Treatment for Anxiety

Also from PCC

Freeze Attacks in Stiff Person Spectrum Disorder Ventilation Weaning, Anxiety, and Valproic Acid Psychological Morbidities in Hospital Staff During Nipah Virus

From the Editors

New Series The JCP Podcast Lamotrigine clearance can rise by 200% to 300% in pregnancy, turning a previously stable dose into therapeutic failure, while the postpartum reset can make that same dose toxic fast. This conversation gets practical about monitoring, tapering, and why screening for bipolar disorder in postpartum depression can change treatment decisions.

About the Authors

This PDF is free for all visitors!

The Primary Care Companion journal cover featuring psychiatric research articles

Vol 28 • 2026 • Number 3

Read the Current Issue

Original Research

Primary Users of the VA Health Care System

Original Research

Lorazepam vs. Diazepam in AUD

Original Research

Readability of Self-Reported Psychosis Measures

Original Research

Prevalence of Anxiety in an Underserved Population

Review Article

Buprenorphine for Pain in Sickle Cell Disease

Rounds in the General Hospital

Differentiating Bipolar and Other Psychiatric Disorders
View current Issue

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe